These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor. Ruzza C, Asth L, Guerrini R, Trapella C, Gavioli EC. Neuropharmacology; 2015 Oct; 97():1-6. PubMed ID: 25979487 [Abstract] [Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1. Camarda V, Ruzza C, Rizzi A, Trapella C, Guerrini R, Reinscheid RK, Calo G. Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665 [Abstract] [Full Text] [Related]
6. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O. Neuron; 2004 Aug 19; 43(4):487-97. PubMed ID: 15312648 [Abstract] [Full Text] [Related]
7. Central Neuropeptide S inhibits food intake in mice through activation of Neuropeptide S receptor. Peng YL, Han RW, Chang M, Zhang L, Zhang RS, Li W, Han YF, Wang R. Peptides; 2010 Dec 19; 31(12):2259-63. PubMed ID: 20800637 [Abstract] [Full Text] [Related]
8. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat. Cifani C, Micioni Di Bonaventura MV, Cannella N, Fedeli A, Guerrini R, Calo G, Ciccocioppo R, Ubaldi M. Peptides; 2011 Jan 19; 32(1):44-50. PubMed ID: 20971145 [Abstract] [Full Text] [Related]
9. The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S. Fedeli A, Braconi S, Economidou D, Cannella N, Kallupi M, Guerrini R, Calò G, Cifani C, Massi M, Ciccocioppo R. Eur J Neurosci; 2009 Oct 19; 30(8):1594-602. PubMed ID: 19821837 [Abstract] [Full Text] [Related]
11. Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. Pulga A, Ruzza C, Rizzi A, Guerrini R, Calo G. Eur J Neurosci; 2012 Dec 19; 36(11):3531-7. PubMed ID: 22928868 [Abstract] [Full Text] [Related]
12. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor. Ruzza C, Pulga A, Rizzi A, Marzola G, Guerrini R, Calo' G. Neuropharmacology; 2012 Apr 19; 62(5-6):1999-2009. PubMed ID: 22248636 [Abstract] [Full Text] [Related]
13. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. Camarda V, Rizzi A, Ruzza C, Zucchini S, Marzola G, Marzola E, Guerrini R, Salvadori S, Reinscheid RK, Regoli D, Calò G. J Pharmacol Exp Ther; 2009 Feb 19; 328(2):549-55. PubMed ID: 18971372 [Abstract] [Full Text] [Related]
15. Neuropeptide S as a novel arousal promoting peptide transmitter. Reinscheid RK, Xu YL. FEBS J; 2005 Nov 19; 272(22):5689-93. PubMed ID: 16279934 [Abstract] [Full Text] [Related]
16. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice. Han RW, Chang M, Peng YL, Qiao LY, Yin XQ, Li W, Wang R. Peptides; 2009 Jul 19; 30(7):1313-7. PubMed ID: 19540430 [Abstract] [Full Text] [Related]
17. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats. Kotlinska J, Pachuta A, Bochenski M, Silberring J. Peptides; 2009 Jun 19; 30(6):1165-72. PubMed ID: 19463751 [Abstract] [Full Text] [Related]
18. The ventromedial hypothalamic nucleus plays an important role in anxiolytic-like effect of neuropeptide S. Jiang JH, Peng YL, Zhang PJ, Xue HX, He Z, Liang XY, Chang M. Neuropeptides; 2018 Feb 19; 67():36-44. PubMed ID: 29195839 [Abstract] [Full Text] [Related]
19. Caffeine treatment regulates neuropeptide S system expression in the rat brain. Lage R, Diéguez C, López M. Neurosci Lett; 2006 Dec 13; 410(1):47-51. PubMed ID: 17055161 [Abstract] [Full Text] [Related]
20. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist. Kłodzińska A, Tatarczyńska E, Stachowicz K, Chojnacka-Wójcik E. J Physiol Pharmacol; 2004 Mar 13; 55(1 Pt 1):113-26. PubMed ID: 15082872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]